anmelden
Länder Analysen: Schweiz
| 12.12.25 | Givaudan Neutral | UBS AG | |
| 12.12.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.12.25 | Givaudan Buy | Jefferies & Company Inc. | |
| 11.12.25 | Givaudan Overweight | Barclays Capital | |
| 11.12.25 | Richemont Overweight | Barclays Capital | |
| 10.12.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 10.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 09.12.25 | Swiss Re Kaufen | DZ BANK | |
|
Werbung
|
|||
| 09.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 09.12.25 | Nestlé Hold | Deutsche Bank AG | |
| 09.12.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 09.12.25 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.12.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 08.12.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 08.12.25 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 08.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 06.12.25 | Swiss Re Underweight | Barclays Capital | |
| 06.12.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 06.12.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 05.12.25 | UBS Outperform | RBC Capital Markets | |
| 05.12.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 04.12.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 04.12.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.12.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.12.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.12.25 | Richemont Buy | Deutsche Bank AG | |
| 01.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 28.11.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 27.11.25 | Richemont Buy | UBS AG | |
| 26.11.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 25.11.25 | Nestlé Market-Perform | Bernstein Research | |
| 25.11.25 | UBS Underweight | Barclays Capital | |
| 24.11.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 24.11.25 | Givaudan Buy | Deutsche Bank AG | |
| 21.11.25 | Novartis Neutral | UBS AG | |
| 21.11.25 | Novartis Buy | Deutsche Bank AG | |
| 21.11.25 | Novartis Underweight | Barclays Capital | |
| 21.11.25 | Novartis Outperform | Bernstein Research | |
| 20.11.25 | Novartis Neutral | UBS AG | |
| 20.11.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 19.11.25 | Zurich Insurance Verkaufen | DZ BANK | |
| 19.11.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 19.11.25 | Richemont Hold | Deutsche Bank AG | |
| 19.11.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.11.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |